Resolution (EU) 2024/2283 of the European Parliament of 11 April 2024 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the European Chemicals Agency for the financial year 2022
Date: 2024-04-11
Institutions: European Parliament
Subjects: European Chemicals Agency, budgetary discharge, financial year, general budget (EU)








L_202402283EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2024/2283


10.10.2024







            RESOLUTION (EU) 2024/2283 OF THE EUROPEAN PARLIAMENT
         
of 11 April 2024
         
with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the European Chemicals Agency for the financial year 2022


THE EUROPEAN PARLIAMENT,






—


having regard to its decision on discharge in respect of the implementation of the budget of the European Chemicals Agency for the financial year 2022,










—


having regard to Rule 100 of and Annex V to its Rules of Procedure,










—


having regard to the opinion of the Committee on the Environment, Public Health and Food Safety,










—


having regard to the report of the Committee on Budgetary Control (A9-0135/2024),










A.


whereas, according to its statement of revenue and expenditure (1), the final budget of the European Chemicals Agency (the ‘Agency’) for the financial year 2022 was EUR 114 777 691 representing an increase of 5,83 % compared to 2021; whereas the budget of the Agency is funded from mainly two sources of revenue, namely, collected fees and the contribution from the general budget of the Union;










B.


whereas the Court of Auditors (the ‘Court’) in its report on the annual accounts of the Agency for the financial year 2022 (the ‘Court’s report’), states that it has obtained reasonable assurance that the Agency’s annual accounts are reliable and that the underlying transactions are legal and regular;










C.


whereas with regard to the Agency’s procurement sector, no issues requiring corrective actions were reported for 2022, nor are there ongoing or outstanding corrective actions from previous years’ audits and assessments;










D.


whereas with regard to the Agency’s internal control systems, no issues requiring corrective actions were reported for 2022, nor are there ongoing or outstanding corrective actions from previous years’ audits and assessments;






Budget and financial management









1.


Notes with satisfaction that budget monitoring efforts during the financial year 2022 resulted in a budget implementation rate of current year commitment appropriations of 98,61 %, representing a slight decrease of 0,23 % compared to 2021 and that the current year payment appropriations execution rate was 85,06 %, representing a decrease of 1,17 % in comparison to 2021;












2.


Recalls that the Agency is financed through fees paid by industry and by an EU balancing contribution, in accordance with Regulation (EC) No 1907/2006 of the European Parliament and of the Council (2), Regulation (EC) No 1272/2008 of the European parliament and of the Council (3) and Regulation (EU) No 528/2012 of the European Parliament and of the Council (4); highlights the fact that, due to the one-off nature of the fees and their dependence on strategic decisions of the chemical industry players, there is high uncertainty as to their amount and timing; recalls that the Commission promised a proposal to strengthen the governance of the Agency and increase the sustainability of its financing model in 2020; insists that the Commission should present it immediately;












3.


Notes with satisfaction that in 2022, for the first time since the final registration deadline under Regulation (EC) No 1907/2006 in 2018, the Agency’s fee income has increased, while reliance on the Union to finance its operations has slightly decreased;





Performance









4.


Observes that the Agency is the driving force in implementing the Union’s chemicals legislation for the benefit of public health and the environment, as well as for innovation and competitiveness; notes that the Agency collects, evaluates and disseminates information on chemicals, helps companies comply with legislation and promotes the safe use of chemicals;












5.


Notes that the Agency implemented 93 % of the Work Programme and achieved 151 of the 162 specific actions and outputs planned for 2022, with 8 actions still ‘in progress’ as planned; notes furthermore that the three ‘not completed’ actions would either have required a contribution from Member States or the work-stream being de-prioritized;












6.


Notes that the Agency focused on delivering its core tasks and on supporting the European Commission to implement its Chemicals Strategy for Sustainability in line with the direction set out by the Management Board in the Strategic Plan 2019-2023 and in its review conducted in 2021;












7.


Draws attention to some of the challenges the Agency faced in 2022, including an inefficient authorisation system, identified in 2021, with a growing number of applications for hexavalent chromium set to continue into 2023, straining the opinion-making capacity of scientific committees, and a lack of experienced members; notes furthermore that a low number of draft assessment reports for biocidal active substances was submitted by Member States, which hinders the completion of evaluations by the end of 2024 as mandated by Regulation (EU) No 528/2012 highlights the fact that, in line with the Active Substances Action Plan, the Agency has made efforts over recent years to support the Member States to make further progress;












8.


Welcomes the Agency’s activities for promoting alternatives to animal testing and the steps taken to increase the effectiveness and visibility of this work;





Efficiency and gains









9.


Commends the Agency for its strategy for efficiency gains, which seeks to achieve added value through performance-based governance, and for the development of the new tools to support planning and reporting, which are more user-friendly, provide better reporting capabilities and save time for all of its staff; notes that the reporting dimensions have been revised to better reflect the Agency’s Work Programme and allow better linking of the Agency-level objectives and those of individual staff members;












10.


Notes that in 2022 the Agency also started an infrastructure capacity optimisation exercise to minimise any excess capacity in the IT infrastructure and that the results from the second half of the year show that the Agency was able to reduce the usage of such infrastructure (both CPU i.e. processors and RAM i.e. memory) by roughly 25 %; welcomes the efforts made in the optimisation exercise and encourages the Agency to continue its efforts in this regard;












11.


Observes that the Agency continues to share its internal audit capability with the EU Agency for the Space Programme (formerly the European Global Navigation Satellite Systems Agency); notes that the Agency and the European Food Safety Authority maintain regular contacts at working and senior management level, where cooperation opportunities are routinely assessed (by conducting a detailed review of the work programmes) and exploited;












12.


Notes furthermore that the Agency continued its strategic cooperation with the European Food Safety Authority on providing the data format IUCLID as a service, delivered from its Cloud Services, for the European Food Safety Authority’s work under Regulation (EC) No 1107/2009 of the European Parliament and of the Council (5) and, as a result, economies of scale were achieved by building on existing IT platforms;












13.


Recalls the importance of increasing the digitalisation of the Agency in terms of internal operation and management but also in order to speed up the digitalisation of procedures; stresses the need for the Agency to continue to be proactive in this regard in order to avoid a digital gap between the agencies; draws attention, however, to the need to take all the necessary security measures to avoid any risk to the online security of the information processed; insists on the need to step up action against cyberattacks or infiltration attempts particularly those originating from Russia or China;












14.


Welcomes the fact that the Agency, in cooperation with the European Food Safety Authority, has taken steps to promote the ‘one substance – one assessment’ principle to ensure greater consistency in the hazard and risk assessment of active substances;





Staff policy









15.


Notes that, on 31 December 2022, the establishment plan was 98,07 % executed, with 458 temporary agents appointed out of 467 temporary agents authorised under the Union budget (same number of authorised posts as in 2021); notes that in addition 128 contract agents, 48 interims, five consultants and 2 seconded national experts worked for the Agency in 2022;












16.


Recalls the importance of ensuring staff gender balance and welcomes in this regard the fact that the Agency has put into effect an action plan to implement the objectives of its Charter on Diversity and Inclusion adopted in 2022, aiming to achieve gender balance in the management team, among other inclusion measures; asks the Agency to report to the discharge authority about the implementation of its action plan; acknowledges that achieving results in this area takes time; notes, however, that the gender balance within the Agency’s senior and middle management has slightly decreased with 76 % positions occupied by men (82 % in 2021) and 24 % by women (18 % in 2021); notes that gender balance in the staff overall is 261 men (45 %) and 317 women (55 %);












17.


Notes with satisfaction that, as of 31 December 2022, the Agency employed staff from 26 Member States; notes that 32 % of its staff are nationals of the Member State where the Agency is located; recalls the importance of geographical balance and encourages the Agency to continue to take the necessary measures to have a balanced and fair geographical representation; is, however, concerned about the geographical balance within the Agency’s senior and middle management having only one director from Central-Eastern Europe; insists that improvements have to be made; asks the Agency to report back on this to the discharge authority;












18.


Notes that the Agency has a policy on protecting the dignity of the person and preventing psychological and sexual harassment, and that the Agency is part of the interagency task force of confidential counsellors; looks forward to receiving their report and recommendations; notes that there were no reported cases of harassment in 2022 and encourages the Agency to continue and develop the work to prevent cases in the future as well;












19.


Notes that, as of March 2022, the Agency’s staff started to return gradually to the Agency’s premises, ending with the implementation of new hybrid working rules in October 2022; notes in this context that the new rules promote flexibility and staff empowerment while maintaining social cohesion and collaboration through regular weekly presence at the office;












20.


Observes that the Agency made use of more internal mobility to respond to the evolving needs for scientific, technical and administrative expertise in its work; notes that this offered career enhancement opportunities and thereby contributed to motivating the Agency’s staff and maintaining a culture of high performance, continuous improvement and responsiveness; welcomes the fact that, to motivate employees and build skill sets, it also introduced new initiatives including mentoring and coaching;












21.


Underlines the necessity of ensuring adequate staffing reflecting the needs of the European Green Deal and the Union Chemical Strategy for Sustainability, Circular Economy Action Plan and, in particular, the zero pollution target and the associated increase in tasks;





Prevention and management of conflicts of interest and transparency









22.


Notes that, based on a thorough risk assessment of its activities, the Agency has identified the processes and sub-processes that require conflicts of interest to be managed; notes furthermore that in all of those processes, a review of the annual declarations of interest is performed by the process owner each time a task is assigned to a staff member, while for some sensitive processes this is complemented with a case-specific declaration of no interest by the member of staff;












23.


Welcomes the fact that, to improve post-employment conflict of interest practice, the Agency’s conflict of interest policy was last revised by the Management Board in June 2023; notes that the changes introduced strengthen the systematic monitoring of compliance with post-employment duties by former Agency staff members, in line with the recommendations of the European Court of Auditors and observations of the discharge authority in previous years;












24.


Observes that the Agency publishes on its website the meetings held by its senior management with interest group representatives;












25.


Welcomes the fact that, during 2022, the Agency introduced a new electronic tool for collecting and reviewing the annual declarations of interest of the external experts contributing to the Agency’s work, providing further assurance to the process;












26.


Notes with satisfaction that the Agency’s Anti-Fraud Strategy was last revised by its Management Board in December 2022 and focuses on maintaining and further developing the anti-fraud culture in the Agency and regularly reviewing key policies and procedures; notes that the strategy strengthens the internal anti-corruption mechanism by specifying the roles and responsibilities for fraud prevention and the means and resources which are engaged in tackling fraud; welcomes the fact that all the Agency’s staff participated in anti-fraud training in 2022; notes with satisfaction that the Agency has guidelines in place for whistleblowers so that the Agency’s employees can provide notification of any activity which goes against the public interest;












27.


Recalls that the decision-making processes of the Agency are designed to be clear, open and to ensure a balanced outcome based on a reasoned scientific approach; notes that information on the intentions of the Agency and the Member States, for example, to look into substances or create dossiers is available online, so companies have access to the data they need to make informed business decisions; notes furthermore that accredited stakeholder organisations may participate in scientific meetings as observers, except where confidential business information requires sessions to be closed; notes, furthermore, that the reflections, opinions and conclusions of the Agency’s scientific committees are recorded in opinions and minutes and these are published online;












28.


Recalls the importance for the Agency of developing greater visibility in the media, internet and social media, in order to make its work known to the citizens;





Other comments









29.


Welcomes the fact that in 2022 the Agency adopted a cybersecurity policy and performed an IT-wide risk assessment exercise; notes, furthermore, that the Agency has introduced the possibility of biometric authentication, improved the visibility of the security operations centre and has conducted failover testing between datacentres;












30.


Notes with satisfaction that in 2022 the Agency joined PPMT (the European Commission’s Public Procurement Management Tool) trial phase in order to test this e-procurement tool (before its complete onboarding in 2023); notes that the Agency had already onboarded other e-procurement tools such as eTendering or eSubmission and in parallel, it renewed in 2022 its subscription to Cloudia – the e-procurement platform of Hansel (central purchasing body for Finnish public authorities) so that all administrative procurement carried out through Hansel is fully digitalised;












31.


Observes that the Agency’s Eco-Management and Audit Scheme (EMAS) and ISO 14001 certificates were successfully renewed in 2022; notes with satisfaction from the Court’s report that the Agency is among the agencies that issue an annual environmental statement;












32.


Highlights the fact that the Agency has continued its efforts to phase out animal testing in Europe to the extent possible under the current regulatory framework; notes that the Agency promotes alternatives to animal testing in three ways: focusing on groups of substances through a separate strategy, investing in international activities that promote alternatives and new approach methodologies, and making the data the Agency holds available; reiterates its call on the Agency to speed up the phasing out process; notes in addition that the Agency is collaborating with the Commission and other stakeholders to support the Commission in developing a roadmap towards the full replacement of animal testing for chemicals;












33.


Welcomes the fact that the Agency has continued to implement different measures to increase its public and online presence through new releases and numerous updates on its website, the launch of a joint Instagram channel with four agencies called ‘One Health One Environment’, and its presence in social media; notes in this context a growth of the general media coverage and an increase in the Agency’s social media metrics in 2022 compared to 2021;












34.


Refers, for other observations of a cross-cutting nature accompanying its decision on discharge, to its resolution of 11 April 2024 (6) on the performance, financial management and control of the agencies.






(1)  
            OJ C 453, 29.11.2022, p. 39.

(2)  Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).

(3)  Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).

(4)  Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1).

(5)  Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (OJ L 309, 24.11.2009, p. 1).

(6)  Texts adopted, P9_TA(2024)0280.


ELI: http://data.europa.eu/eli/res/2024/2283/oj
ISSN 1977-0677 (electronic edition)